India’s push to become self-reliant in pharmaceutical manufacturing has gained strong momentum under the Bulk Drug Park Scheme, a flagship initiative aimed at reducing dependence on imports of active pharmaceutical ingredients (APIs) and key starting materials. Approved by the Union Cabinet in March 2020, the scheme focuses on building world-class…
Tag: #PLIPharma
News
India’s Pharma & MedTech Achieve Historic 2025 Growth
India significantly strengthened its position as a global pharmaceutical and medical technology hub in 2025, with major achievements across affordable healthcare, domestic manufacturing, research innovation, and global collaboration. The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, reported record investments, exports, and innovation milestones during the year. Janaushadhi…